Also trades as: NRXPW (NASDAQ) · $vol 0M
NRXP NASDAQ
NRx Pharmaceuticals, Inc.
1W: -3.0%
1M: -15.9%
3M: -26.3%
YTD: +11.1%
1Y: -12.9%
3Y: +15.9%
5Y: -96.9%
$2.90
+0.06 (+1.93%)
Weekly Expected Move ±5.0%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2023-07-28
Earliest Filing
2025-09-12
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named NRXP in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| NRXPW NRX Pharmaceuticals, Inc. | partner | Parent company of HOPE Therapeutics and acquirer of Dura Medical | 2025-09-12 | View |
| NRXPW NRX Pharmaceuticals, Inc. | target | Company issuing securities to Investor | 2025-02-03 | View |
| NRXPW NRX Pharmaceuticals, Inc. | supplier | Borrower in an amendment to a convertible promissory note | 2023-07-28 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR